Capital Impact Advisors »

Arrowhead Pharmaceuticals shares owned by Capital Impact Advisors

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by Capital Impact Advisors from 13F filings

Historical chart of Capital Impact Advisors investment in Arrowhead Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals held by Capital Impact Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals by Capital Impact Advisors

Quarter filed Position value Share count Share price at filing
2023-06-30 $737k 21k 35.66
2023-03-31 $392k 15k 25.40
2022-12-31 $1.1M 27k 40.56
2022-09-30 $680k 22k 30.58
2022-06-30 $685k 19k 35.23
2022-03-31 $733k 16k 46.01
2021-12-31 $258k 3.9k 66.27
2020-12-31 $6.8M 88k 76.73
2020-09-30 $7.7M 178k 43.06
2020-06-30 $7.7M 178k 43.19
2020-03-31 $2.4M 85k 28.77